Skip to main content

WTW unveils next phase in rollout of its Neuron digital trading platform

Liberty Specialty Markets to use Neuron to undertake live trading of D&O and Cyber risks.

LONDON, April 10, 2025 (GLOBE NEWSWIRE) — WTW (NASDAQ: WTW), a leading global advisory, broking, and solutions company, has today announced that Liberty Specialty Markets (LSM) is now using Neuron, WTW’s digital trading solution, to undertake live trading of Directors & Officers (D&O) and Cyber risks.

LSM capacity became available on Neuron on 31 March 2025. While initially accessible across two open market business classes, Cyber and D&O, the addition of LSM’s capacity aligns with Neuron’s broader expansion, which includes increasing follow capacity with additional classes and partners to be confirmed through 2025.

Neuron connects brokers and insurers in real time, simplifying and accelerating the trading of complex specialty risks, while enhancing efficiency across the insurance value chain. By creating a digital marketplace, where participants keep control of their key assets and flexibility to trade, Neuron is setting the standard for connected ecosystems built on transparency and consistency.

Carol Baker, Head of Digital Strategy at LSM, said: “This latest capability to digitally trade D&O and Cyber risks in real time on Neuron underscores LSM’s wider commitment to expand its digital capabilities, offering brokers a faster, more flexible way to trade risks while enabling tailored portfolio underwriting solutions. This also represents the latest step towards a more connected market overall, making the risk placement process fast and frictionless for follow business, strengthened as additional carriers and brokers join.”

Louise Smith OBE, Global Lead for Neuron at WTW, said: “LSM is a highly respected business in the specialty insurance market and their enthusiasm to partner with Neuron reinforces our shared objective to advance the scope and scale of next-generation digital and data capabilities to improve the speed and cost of doing business.”

Mark Russell-Vick, Head of Broking FINEX GB at Willis, commented: “The London market is rapidly evolving with an increase of capacity becoming attracted to algorithmic capacity offerings. Neuron is breaking new ground which is extremely exciting as we bring future innovations into today’s world for the benefit of global clients.”

Neuron helps brokers find the best products and prices for customers, quickly. Digitally trading follow-insurance through Neuron saves insurers time and allows them to focus expert underwriting resources on more complex risks and new opportunities.

About WTW

At WTW (NASDAQ: WTW), we provide data-driven, insight-led solutions in the areas of people, risk and capital. Leveraging the global view and local expertise of our colleagues serving 140 countries and markets, we help organizations sharpen their strategy, enhance organizational resilience, motivate their workforce and maximize performance.

Working shoulder to shoulder with our clients, we uncover opportunities for sustainable success—and provide perspective that moves you.

Learn more at wtwco.com.

About Liberty Specialty Markets

Liberty Specialty Markets offers specialty and commercial insurance and reinsurance products across key UK, European, Middle East, US, Bermuda, Asia Pacific & Latin America markets. We provide brokers and insureds with a broad product range through both the Company and Lloyd’s markets and have over 2,000 employees in approximately 60 offices.

Media Contact
Andrew Collis: +44 7932 725 267 |   Andrew@acolliscommunications.com

Hannah Clift: +44 7485 929735 |   Hannah.Clift@LibertyGlobalGroup.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.